Author results

1DHM
  • Download 1dhm
  • View 1dhm
Molmil generated image of 1dhm
DNA-BINDING DOMAIN OF E2 FROM HUMAN PAPILLOMAVIRUS-31, NMR, MINIMIZED AVERAGE STRUCTURE
Descriptor:E2 PROTEIN
Authors:Liang, H., Petros, A.P., Meadows, R.P., Yoon, H.S., Egan, D.A., Walter, K., Holzman, T.F., Robins, T., Fesik, S.W.
Deposit date:1995-08-15
Release date:1996-12-07
Last modified:2011-07-13
Method:SOLUTION NMR
Cite:Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions.
Biochemistry, 35, 1996
2JIX
  • Download 2jix
  • View 2jix
Molmil generated image of 2jix
CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
Descriptor:ABT-007 FAB FRAGMENT, ERYTHROPOIETIN RECEPTOR
Authors:Liu, Z., Stoll, V.S., DeVries, P., Jakob, C.G., Xie, N., Simmer, R.L., Lacy, S.E., Egan, D.A., Harlan, J.E., Lesniewski, R.R., Reilly, E.B.
Deposit date:2007-07-02
Release date:2007-07-10
Last modified:2013-10-30
Method:X-RAY DIFFRACTION (3.2 Å)
Cite:A Potent Erythropoietin-Mimicking Human Antibody Interacts Through a Novel Binding Site.
Blood, 110, 2007
1A7G
  • Download 1a7g
  • View 1a7g
Molmil generated image of 1a7g
THE CRYSTAL STRUCTURE OF THE E2 DNA-BINDING DOMAIN FROM HUMAN PAPILLOMAVIRUS AT 2.4 ANGSTROMS
Descriptor:REGULATORY PROTEIN E2, SULFATE ION
Authors:Bussiere, D.E., Giranda, V.L.
Deposit date:1998-03-13
Release date:1999-04-27
Last modified:2011-07-13
Method:X-RAY DIFFRACTION (2.4 Å)
Cite:Structure of the E2 DNA-binding domain from human papillomavirus serotype 31 at 2.4 A.
Acta Crystallogr.,Sect.D, 54, 1998
1CYA
  • Download 1cya
  • View 1cya
Molmil generated image of 1cya
NMR STUDIES OF (U-13C)CYCLOSPORIN A BOUND TO CYCLOPHILIN: BOUND CONFORMATION AND PORTIONS OF CYCLOSPORIN INVOLVED IN BINDING
Descriptor:CYCLOSPORIN A
Authors:Fesik, S.W.
Deposit date:1992-02-24
Release date:1994-01-31
Last modified:2012-12-12
Method:SOLUTION NMR
Cite:NMR Studies of [U-13C]Cyclosporin a Bound to Cyclophilin: Bound Conformation and Portions of Cyclosporin Involved in Binding.
Biochemistry, 30, 1991
1CYB
  • Download 1cyb
  • View 1cyb
Molmil generated image of 1cyb
NMR STUDIES OF (U-13C)CYCLOSPORIN A BOUND TO CYCLOPHILIN: BOUND CONFORMATION AND PORTIONS OF CYCLOSPORIN INVOLVED IN BINDING
Descriptor:CYCLOSPORIN A
Authors:Fesik, S.W.
Deposit date:1992-02-24
Release date:1994-01-31
Last modified:2012-12-12
Method:SOLUTION NMR
Cite:NMR Studies of [U-13C]Cyclosporin a Bound to Cyclophilin: Bound Conformation and Portions of Cyclosporin Involved in Binding.
Biochemistry, 30, 1991
6E99
  • Download 6e99
  • View 6e99
Molmil generated image of 6e99
CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH THE PKI PEPTIDE AND AN AMINO-PYRIDINYLBENZAMIDE BASED INHIBITOR.
Descriptor:cAMP-dependent protein kinase catalytic subunit alpha, PKI peptide, 2-[(2-aminoethyl)amino]-N-[(1R)-1-(3-methoxyphenyl)ethyl]-4-(pyridin-4-yl)benzamide
Authors:Judge, R.A., Hobson, A.D.
Deposit date:2018-07-31
Release date:2018-11-14
Last modified:2019-01-16
Method:X-RAY DIFFRACTION (1.88 Å)
Cite:Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure Based Drug Design.
J. Med. Chem., 61, 2018
6E9L
  • Download 6e9l
  • View 6e9l
Molmil generated image of 6e9l
CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH THE PKI PEPTIDE AND A PYRIDINYLBENZAMIDE BASED INHIBITOR
Descriptor:cAMP-dependent protein kinase catalytic subunit alpha, PKI peptide, N-[(2,3-dihydro-1,4-benzodioxin-5-yl)methyl]-4-(pyridin-4-yl)benzamide
Authors:Judge, R.A., Hobson, A.D.
Deposit date:2018-08-01
Release date:2018-11-14
Last modified:2019-01-16
Method:X-RAY DIFFRACTION (2.8 Å)
Cite:Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure Based Drug Design.
J. Med. Chem., 61, 2018
6E9W
  • Download 6e9w
  • View 6e9w
Molmil generated image of 6e9w
CRYSTAL STRUCTURE OF ROCK1 WITH A PYRIDINYLBENZAMIDE BASED INHIBITOR
Descriptor:Rho-associated protein kinase 1, N-[(2,3-dihydro-1,4-benzodioxin-5-yl)methyl]-4-(pyridin-4-yl)benzamide, SULFATE ION
Authors:Judge, R.A., Hobson, A.D.
Deposit date:2018-08-01
Release date:2018-11-14
Last modified:2019-01-16
Method:X-RAY DIFFRACTION (2.96 Å)
Cite:Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure Based Drug Design.
J. Med. Chem., 61, 2018
6ED6
  • Download 6ed6
  • View 6ed6
Molmil generated image of 6ed6
CRYSTAL STRUCTURE OF ROCK2 WITH A PYRIDINYLBENZAMIDE BASED INHIBITOR
Descriptor:Rho-associated protein kinase 2, N-[(2,3-dihydro-1,4-benzodioxin-5-yl)methyl]-4-(pyridin-4-yl)benzamide
Authors:Judge, R.A., Hobson, A.D.
Deposit date:2018-08-08
Release date:2018-11-14
Last modified:2019-01-16
Method:X-RAY DIFFRACTION (2.86 Å)
Cite:Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure Based Drug Design.
J. Med. Chem., 61, 2018